Great research mate. Much appreciated

First 101 Last

Share
Profile

Follow
Pinky789

1,719 Posts.

188

08/12/20

12:23

Post #: 49419159
Share

Originally posted by sapporo: ↑

Been patiently waiting for a long time for the ship to come in here, and so it was a very pleasant surprise to see this morning they're bringing in a rocket launching pad.

And the opportunity goes out to all holders, at a discount, in an illiquid stock.

First of all, I note 3 of the 4 top performing shares today are cannabis. CP1, while I don't own, is the only one I'd give any consideration.

The sheer delight I get in other crap rising like this is knowing when you are sitting on the bitcoin of ASX cannabis stocks (i.e., in very short supply) and it's going down on the big up day for cannabis; well, had to have a good chuckle.

I will be taking up my full entitlement (for full disclosure have not sold a single share) and it's because I've researched the top 20 over the past 12 months and it tells the underlying story of a growing company at its seed level.

Things are on the up & up here; here's why and it's based on a top 20 list I viewed on the 17th on November (don't have a copy so can't share but made notes and researched the new additions & changes):

#1 Cannvalate (the emerging big dog of the Australian cannabis industry)
#2 M I D Wealth (new company - will get to this later)
#4 Pyxis - long time holder increasing holdings
#5 10 Bolivianos Pty Ltd - original IPO broker Niv Dagan increasing holdings despite being overlooked as the broker for all recent raisings
#7 Ancan Investments (Cannavo Share A/C) - parents of director Frank Cannavo increasing their holdings
#9 Sacco Developments - long time holder
#10 Niv Dagan (see above)
#11 Bliss Hairdressing - a director there, Daniel Stefanetti, is also a director of a medical superannuation/advisory fund called Grimsey (est. 1980's) - a more than fair chance it's the parent company of M I D Wealth (see #2)
#12 Piper Madison - long time holder increasing holdings
#13 Dr Dave Walland - long time holder increasing holdings
#14 Shai Dagan - father of Niv, long time holder & increasing holdings
#15 J & W Crock - most likely brother of Peter Crock CEO of Cann Group
#19 Blaise Bratter - Global Sales Manager of MXC

When the herd are scrambling for cannabis shares, the cannabis industry insiders are scrambling to buy shares in LSH.

Think about that. Who would you rather follow - the herd or the expert insiders?

Let me leave this "pump" with a sober caveat; if the market crashes this will most likely get hit hard, too.

To each their own.

Imo & dyor

Expand

Great research mate. Much appreciated

LSH Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 3 more messages in this thread...

First 101 Last

Add IRX (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $4.830M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	68809	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	89947	2

View Market Depth

No.	Vol.	Price($)
1	68809	0.021
1	253032	0.020
1	100099	0.010
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.025	89947	2
0.028	53320	1
0.030	4400	1
0.033	431682	2
0.036	130000	1

Last trade - 10.04am 07/10/2024 (20 minute delay)

IRX (ASX) Chart

Day chart unavailable

Great research mate. Much appreciated

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Great research mate. Much appreciated

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News